1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow Excessive Daytime Sleepiness: new trials by email Literature Review of Excessive Daytime Sleepiness trials Research Report on Excessive Daytime Sleepiness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness Pitolisant (BF2.649), Placebo Oral Tablet - Excessive Daytime Sleepiness, Obstructive Sleep Apnea | Phase 3 | Withdrawn | Bioprojet | 2017-11-24 |
Disorders of Excessive Somnolence (1) · Sleep Apnea, Obstructive (1)
Apnea (1) · Dyssomnias (1) · Mental Disorders (1) · Nervous System Diseases (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Sleep Apnea Syndromes (1) · Sleep Disorders, Intrinsic (1) · Sleep Wake Disorders (1)
pitolisant (1)
Bioprojet (1)
France (1)
2016 (1)